Sonn stock forecast latest SONN stock forecast data shows

Latest SONN stock forecast data shows correlation with NASDAQ biotech index performance, currently trending upward. Support levels are well-defined, but breakout potential requires confirmation above $0. Sonnet BioTherapeutics Holdings Inc has a consensus price target of $10.18 based on the ratings of 4 analysts. The high is $20 issued by Chardan Capital on April 7, 2025. The low is $6.7 issued... Sonnet BioTherapeutics, Inc. Announces $888 Million Business Combination to Launch a HYPE Cryptocurrency Treasury Reserve Strategy Technical analysts reviewing SONN stock forecast highlight the importance of holding above the 50-day moving average at $0.